Cluster Randomized Trials: Ethics, Regulations, Statistics & Design: Harvard Catalyst Regulatory Symposium
Please join Harvard Catalyst for a free half-day symposium on the topic of Cluster Randomized Trials: Ethics, Regulations, Statistics & Design. We will provide a general overview of Cluster Randomized Trials and take a deeper look through the lenses of Ethics, Regulatory and Biostatistics. All are welcome; target audience is Institutional Review Board members, investigators and statisticians.
Bray Room, Joseph B. Martin Conference Center
77 Avenue Louis Pasteur, Boston MA
Michael Hughes, PhD, Director of the Center for Biostatistics in AIDS Research
Holly Fernandez Lynch, JD, MBioethics, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School
Michele Russell-Einhorn, JD, Senior Director, Dana-Farber Cancer Institute
Rui Wang, PhD, Assistant Professor in Biostatistics
Learn More and Register
Register here: http://tinyurl.com/zlvy7zb
Contact Kate McGroarty with any questions: Kathleen_McGroarty@hms.harvard.edu
Co-Sponsored by Harvard Catalyst’s Regulatory Foundations, Ethics, and Law and Biostatistics Program.
Established in 2008, Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators. As a shared enterprise of the University, Harvard Catalyst is funded by the NIH, Harvard University, and its affiliated healthcare centers. Resources are freely available to all Harvard faculty, regardless of institutional affiliation or academic degree.bioethics clinical research health law policy holly fernandez lynch human subjects research regulation research